$1.68
0.010.6%
At close: Nov 13, 4:00 PM EST
$1.66
-0.0189-1.12%
After Hours: 7:07 PM EST
OPKO Health Inc
OPKNASDAQ
OPKO Health rose 31.3% from $1.28 to $1.68, ahead of the S&P 500's +12.3%. Its worst day was Jul 29 (−17.3%), and its low came Mar 30 at $1.10.
Nov 14, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.04 beat the $-0.07 estimate on $148.5M revenue (est. $139.1M); Q1 revenue guidance of $125.0M–$140.0M against the $139.1M consensus.
0.0% · S&P 500 −0.5%
Story events cover the past 12 months · Times ET
OPKO Health closed at its lowest level of the year, 14.1% below where the year started.
−1.8% · S&P 500 −0.3%
EPS of $-0.07 beat the $-0.07 estimate on $124.2M revenue (est. $130.7M); FY revenue guidance of $530.0M–$560.0M against the $545.5M consensus.
−8.3% · S&P 500 0.0%
OPKO Health shares rose 10.0%, while the S&P 500 rose 0.6%.
+10.0% · S&P 500 +0.6%
EPS of $-0.01 beat the $-0.10 estimate on $163.5M revenue (est. $131.2M); FY revenue guidance of $560.0M–$585.0M against the $536.4M consensus.
+33.1%, the year's best day · S&P 500 +0.2%
OPKO Health shares rose 11.2%, while the S&P 500 rose 0.4%.
+11.2% · S&P 500 +0.4%
OPKO Health shares rose 17.5%, while the S&P 500 rose 0.3%.
+17.5%, on 55M shares, the year's heaviest volume · S&P 500 +0.3%
EPS of $-0.05 beat the $-0.06 estimate on $65.4M revenue (est. $136.5M); FY revenue guidance of $268.0M–$278.0M.
−1.1% · S&P 500 −4.4%
Where it ended: a close of $1.68 on Nov 13, 2026. Up next: Q4 2026 earnings on Feb 25, 2027 (EPS est. $-0.05, revenue est. $67.2M).
Nothing in the past 12 months.
All OPK dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for OPK and SPY from Benzinga historical bars. Not investment advice.
